Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Dec 07, 2016
Optimization of Supercritical CO2 Assisted Spray Drying for the Production of Inhalable Composite Particles
Read more
Scientific Article
/ Dec 07, 2016
Breathing Simulators: One step closer to representative deposition profiles?
Read more
Scientific Article
/ Dec 07, 2016
Paddle over disk as a dissolution test for orally inhaled drugs: discriminating composite from carrier-based formulations
Read more
Scientific Article